#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3101514	A	Half life in Wistar rat at 10 mg/kg, po	Rattus norvegicus	2	ALA3098073	organism-based format	Scientific Literature
2.	ALA3101515	A	Oral bioavailability in Wistar rat at 10 mg/kg	Rattus norvegicus	2	ALA3098073	organism-based format	Scientific Literature
3.	ALA3101516	A	AUC (0 to infinity) in Wistar rat at 10 mg/kg, po	Rattus norvegicus	2	ALA3098073	organism-based format	Scientific Literature
4.	ALA3101517	A	Apparent oral clearance in Wistar rat at 10 mg/kg, po	Rattus norvegicus	2	ALA3098073	organism-based format	Scientific Literature
5.	ALA3102014	P	Lipophilicity, log D of the compound at pH 7.4 by shake-flask method		2	ALA3098073	small-molecule physicochemical format	Scientific Literature
6.	ALA3102015	A	Cmax in Wistar rat at 10 mg/kg, po	Rattus norvegicus	2	ALA3098073	organism-based format	Scientific Literature
7.	ALA3102016	A	Protein binding in human plasma	Homo sapiens	2	ALA3098073	cell-free format	Scientific Literature
8.	ALA3102017	P	Dissociation constant, pKa of the compound by potentiometric method		2	ALA3098073	small-molecule physicochemical format	Scientific Literature
9.	ALA3102018	P	Solubility of the compound at pH 7.4		2	ALA3098073	small-molecule physicochemical format	Scientific Literature
10.	ALA3102019	P	Solubility of the compound at pH 1		2	ALA3098073	small-molecule physicochemical format	Scientific Literature
11.	ALA3102020	A	Apparent permeability of the compound from basolateral to apical direction in human Caco2 cells	Homo sapiens	2	ALA3098073	cell-based format	Scientific Literature
12.	ALA3102021	A	Apparent permeability of the compound from apical to basolateral direction in human Caco2 cells	Homo sapiens	2	ALA3098073	cell-based format	Scientific Literature
13.	ALA3102022	B	Antagonist activity at CRTh2 in human RBC assessed as inhibition of PGD2-induced eosinophil shape change	Homo sapiens	2	ALA3098073	single protein format	Scientific Literature
14.	ALA3102023	F	Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by liquid scintillation counting in presence of 1% human serum albumin	Homo sapiens	2	ALA3098073	cell-based format	Scientific Literature
15.	ALA3102127	F	Antagonist activity at CRTh2 (unknown origin) expressed in CHO.K1 cells assessed as inhibition of PGD2-induced [35S]-GTPgammaS binding after 2 hrs by liquid scintillation counting	Homo sapiens	38	ALA3098073	cell-based format	Scientific Literature
16.	ALA3102129	B	Antagonist activity at CRTh2 in human whole blood assessed as inhibition of PGD2-induced eosinophil shape change	Homo sapiens	3	ALA3098073	single protein format	Scientific Literature
17.	ALA3778970	B	Displacement of [35S]-GTPgammaS from CRTH2 receptor (unknown origin) expressed in CHOK1 cell membrane after 1 hr by liquid scintillation counter	Homo sapiens	22	ALA3774370	cell-based format	Scientific Literature
18.	ALA3778972	B	Antagonist activity at CRTH2 receptor (unknown origin) expressed in CHOK1 cells assessed as dissociation half life measured up to 25 hrs by GTPgammaS assay	Homo sapiens	26	ALA3774370	cell-based format	Scientific Literature